AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitamaze-M XR 100/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Biotics Lab Life Services Private Limited

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitamaze-M XR 100/1000 Tablet

Diabexe Duo XR 100/1000 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, and may lessen the risk of stroke or heart attack. Diabexe Duo XR 100/1000 may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and treat this complication. This medication isn't suitable for everyone. Inform your doctor of any prior kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should also seek medical counsel. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Primary Ingredients of Sitamaze-M XR 100/1000 Tablet

No text was provided. Please provide the text you wish me to rephrase.

Uses of Sitamaze-M XR 100/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitamaze-M XR 100/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitamaze-M XR 100/1000 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Sitamaze-M XR 100/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamaze-M XR 100/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitamaze-M XR 100/1000 Tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Sitamaze-M XR 100/1000 Tablet works:

Sitamaze-M XR 100/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitamaze-M XR 100/1000 Tablets poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitamaze-M XR 100/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitamaze-M XR 100/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitamaze-M XR 100/1000 tablets, potentially requiring dosage modification. Consult a physician for guidance. Sitamaze-M XR 100/1000 tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Sitamaze-M XR 100/1000 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitamaze-M XR 100/1000 Tablet :

Should you forget a dose of Sitamaze-M XR 100/1000 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitamaze-M XR 100/1000 Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitamaze-M XR 100/1000 Tablet

Sitamaze-M XR 100/1000 tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps control blood sugar when combined with a healthy diet and exercise regimen. Metformin reduces glucose production by the liver and enhances insulin responsiveness. Sitagliptin blocks DPP-4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitamaze-M XR 100/1000 Tablet use can lead to Vitamin B12 deficiency by impairing its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Patients may experience symptoms such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Sitamaze-M XR 100/1000 Tablet may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamaze-M XR 100/1000 Tablet constituents or inactive ingredients should not use this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze-M XR 100/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Sitamaze-M XR 100/1000 Tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is heightened in patients with pre-existing kidney impairment, advanced age, or significant alcohol consumption, thus contraindicating Sitamaze-M XR 100/1000 in these individuals. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms arise, discontinue Sitagliptin + Metformin immediately and seek prompt medical attention.
The combination drug Sitamaze-M XR 100/1000 Tablet contains sitagliptin and metformin, and is prescribed for adult patients with type 2 diabetes. This medication helps manage blood sugar levels when used in conjunction with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin functions by suppressing DPP-4 enzyme activity, thus boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under the age of 18.
Sitamaze-M XR 100/1000 Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamaze-M XR 100/1000 Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze-M XR 100/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 100/1000mg extended-release tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is an uncommon adverse reaction to metformin. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Presenting symptoms might encompass muscular discomfort or weakness, vertigo, fatigue, peripheral cold sensations, dyspnea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitamaze-M XR 100/1000 Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Therefore, preventative supplemental vitamin B12 administration, at least annually, is recommended by some studies.
Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the container or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitamaze-M XR 100/1000 tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin responsiveness, while sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitamaze-M XR 100/1000 Tablet administration may cause prevalent adverse reactions including hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Rare but potentially severe adverse events such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamaze-M XR 100/1000 Tablet constituents or inactive ingredients should not use this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze-M XR 100/1000 Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential side effect of Sitamaze-M XR 100/1000 Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin use and necessitates avoidance in individuals with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitamaze-M XR 100/1000 Tablet use can indeed lead to Vitamin B12 deficiency. This is due to the medication's interference with Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended annually by some experts.
Retain this medication within its original, tightly sealed container. Follow the storage guidelines specified on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitamaze-M XR 100/1000 Ta...
128
MRP 149
14% off